生物标记临床阶段外包服务市场 - 按生物标记类型（预测、预后、替代）、治疗领域（肿瘤学、神经病学）、最终用户（製药和生物技术公司）、全球预测，2024-2032 年

由于对个人化医疗的日益关注，全球生物标记临床阶段外包服务市场将从 2024 年到 2032 年以 19.2% 的CAGR成长。随着医疗保健产业转向客製化治疗方法，生物标记在患者分层和治疗优化中发挥关键作用。外包服务对于满足生物标记驱动的临床试验的特殊需求、确保效率和专业知识变得至关重要。随着对个人化医疗潜力的日益认识，对外包服务的需求将激增，推动市场的扩张。

製造商正在采用创新并推出临床试验配方，从而提高其行业份额并为持续成长做好准备。例如，2023 年，创新试验推出了以患者为中心的新型服务，旨在协助申办者和研究中心加快其疗法的进展。

生物标记临床阶段外包服务产业根据生物标记类型、治疗领域和地区进行分类。

到 2032 年，预测性生物标记领域将取得显着进展。随着个人化医疗的日益突出，对精确患者分层的需求不断增强，使得预测性生物标记在临床试验中不可或缺。它们在预测治疗反应方面的作用提高了试验效率和成功率。以客製化疗法为重点，预测生物标记细分市场将成为关键参与者，巩固其主导地位，并为市场成长做出重大贡献。

到2032 年，神经病学领域的生物标记临床阶段外包服务市场规模将大幅上升。神经系统疾病的日益流行促使该治疗领域的研究和开发增加，从而提高了对生物标誌物驱动的临床试验的需求。随着精准医学在神经病学领域日益受到重视，这些试验的专业性使得外包服务成为必要。由于专注于推进神经系统疾病的诊断和治疗，神经病学领域将成为塑造市场前景的核心驱动力。

欧洲生物标记临床阶段外包服务产业将于2024年至2032年实现显着的CAGR。该地区强劲的製药业、先进的医疗基础设施和严格的监管环境有助于其突出地位。对尖端研究的承诺和对个人化医疗的关注将使欧洲成为生物标记驱动的临床试验的中心。凭藉完善的临床研究组织网络，欧洲将吸引大量投资，巩固其作为市场扩张主要贡献者的角色。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：生物标记临床阶段外包服务市场洞察

• 产业格局
• 产业影响力
  • 成长动力
    • 生物标记技术的快速进步
    • 增加生物标誌物的使用
    • 政府措施和资金不断增加
  • 产业陷阱与挑战
    • 监理合规性
• 成长潜力分析
• 监管环境
• 波特的分析
• PESTEL分析

第 4 章：竞争格局

• 介绍
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 战略仪錶板

第 5 章：生物标记临床阶段外包服务市场估计与预测：按生物标记类型，2018-2032

• 主要动向：依生物标记类型
• 替代终点
• 预测性生物标记
• 预后生物标记
• 安全生物标记
• 其他生物标记类型

第 6 章：生物标记临床阶段外包服务市场估计与预测：按治疗领域，2018-2032 年

• 主要动向：依治疗领域
• 肿瘤学
• 神经病学
• 心臟病学
• 自体免疫疾病
• 其他治疗领域

第 7 章：生物标记临床阶段外包服务市场估计与预测：按最终用户，2018-2032 年

• 主要动向：由最终用户
• 製药公司
• 生技公司
• 其他最终用户

第 8 章：生物标记临床阶段外包服务市场估计与预测：按地区，2018 - 2032

• 主要动向：按地区
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 拉丁美洲其他地区
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 中东和非洲其他地区

第 9 章：公司简介

• Laboratory Corporation of America Holdings
• Parexel International Corporation
• Charles River Laboratories International, Inc.
• ICON plc
• Proteome Sciences plc
• Fujirebio Inc.
• WuXi AppTec Co., Ltd.
• NorthEast BioAnalytical Laboratories LLC.
• Celerion, Inc.
• GenScript ProBio Co., Ltd.

Global Biomarker Clinical Phase Outsourcing Services Market will grow at a 19.2% CAGR from 2024 to 2032, attributed to the escalating focus on personalized medicine. As the healthcare industry pivots towards tailored therapeutic approaches, biomarkers are pivotal in patient stratification and treatment optimization. Outsourcing services have become crucial to meet the specialized demands of biomarker-driven clinical trials, ensuring efficiency and expertise. With the increasing recognition of personalized medicine's potential, the demand for outsourcing services will surge, driving the expansion of the market.

Manufacturers are adopting innovations and launching clinical trial formulations, thus bolstering their industry share and positioning themselves for sustained growth. For instance, in 2023, Innovative Trials introduced a novel patient-centric service aimed at assisting sponsors and sites in expediting the advancement of their therapies.

The biomarker clinical phase outsourcing services industry is classified based on biomarker type, therapeutic area, and region.

The predictive biomarker segment will garner remarkable gains by 2032. As personalized medicine gains prominence, the demand for precise patient stratification intensifies, making predictive biomarkers indispensable in clinical trials. Their role in forecasting treatment responses enhances trial efficiency and success rates. With a focus on tailored therapies, the predictive biomarker segment will stand as a key player, solidifying its dominance and contributing significantly to the market growth.

The biomarker clinical phase outsourcing services market size from the neurology segment will witness a substantial upswing by 2032. The growing prevalence of neurological disorders prompts increased research and development in this therapeutic area, elevating the demand for biomarker-driven clinical trials. As precision medicine gains prominence in neurology, the specialized nature of these trials necessitates outsourcing services. With a focus on advancing diagnostics and therapeutics for neurological conditions, the neurology segment will emerge as a central driver, shaping the market outlook.

Europe biomarker clinical phase outsourcing services industry will register a significant CAGR from 2024 to 2032. The region's robust pharmaceutical industry, advanced healthcare infrastructure, and stringent regulatory environment contribute to its prominence. The commitment to cutting-edge research and a focus on personalized medicine will position Europe as a hub for biomarker-driven clinical trials. With a well-established network of clinical research organizations, Europe will attract substantial investments, solidifying its role as the primary contributor to market expansion.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market definition
• 1.2 Base estimates & calculations
• 1.3 Forecast calculation
• 1.4 Data validation
• 1.5 Data sources
  • 1.5.1 Primary
  • 1.5.2 Secondary
    • 1.5.2.1 Paid sources
    • 1.5.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Biomarker clinical phase outsourcing services industry 360 degree synopsis, 2018 - 2032 (USD Million)
  • 2.1.1 Business trends
  • 2.1.2 Regional trends
  • 2.1.3 Biomarker type trends
  • 2.1.4 Therapeutic area trends
  • 2.1.5 End-user trends

Chapter 3 Biomarker Clinical Phase Outsourcing Services Market Insights

• 3.1 Industry landscape, 2018 - 2032 (USD Million)
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rapid advancements in biomarker technology
    • 3.2.1.2 Increasing use of biomarkers
    • 3.2.1.3 Rising government initiatives and funding
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Regulatory compliance
• 3.3 Growth potential analysis
  • 3.3.1 By biomarker type
  • 3.3.2 By therapeutic area
  • 3.3.3 By end-user
• 3.4 Regulatory landscape
• 3.5 Porter's analysis
• 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

• 4.1 Introduction
• 4.2 Company matrix analysis, 2022
• 4.3 Competitive analysis of major market players, 2022
• 4.4 Competitive positioning matrix, 2022
• 4.5 Strategic dashboard, 2022

Chapter 5 Biomarker Clinical Phase Outsourcing Services Market Estimates and Forecast, By Biomarker Type, 2018-2032 (USD Million)

• 5.1 Key trends, by biomarker type
• 5.2 Surrogate endpoints
• 5.3 Predictive biomarker
• 5.4 Prognostic biomarker
• 5.5 Safety biomarker
• 5.6 Other biomarker types

Chapter 6 Biomarker Clinical Phase Outsourcing Services Market Estimates and Forecast, By Therapeutic Area, 2018-2032 (USD Million)

• 6.1 Key trends, by therapeutic area
• 6.2 Oncology
• 6.3 Neurology
• 6.4 Cardiology
• 6.5 Autoimmune diseases
• 6.6 Other therapeutic areas

Chapter 7 Biomarker Clinical Phase Outsourcing Services Market Estimates and Forecast, By End-user, 2018-2032 (USD Million)

• 7.1 Key trends, by end-user
• 7.2 Pharmaceutical companies
• 7.3 Biotechnology companies
• 7.4 Other end-users

Chapter 8 Biomarker Clinical Phase Outsourcing Services Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)

• 8.1 Key trends, by region
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Rest of Latin America
• 8.6 Middle East & Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 Rest of Middle East & Africa

Chapter 9 Company Profiles

• 9.1 Laboratory Corporation of America Holdings
• 9.2 Parexel International Corporation
• 9.3 Charles River Laboratories International, Inc.
• 9.4 ICON plc
• 9.5 Proteome Sciences plc
• 9.6 Fujirebio Inc.
• 9.7 WuXi AppTec Co., Ltd.
• 9.8 NorthEast BioAnalytical Laboratories LLC.
• 9.9 Celerion, Inc.
• 9.10 GenScript ProBio Co., Ltd.

Data Tables

• TABLE 1 Market revenue, by biomarker type (2023)
• TABLE 2 Market revenue, by therapeutic area (2023)
• TABLE 3 Market revenue, by end-user (2023)
• TABLE 4 Market share, by region (2023)
• TABLE 5 Global biomarker clinical phase outsourcing services market size, by region, 2018 - 2023 (USD Million)
• TABLE 6 Global biomarker clinical phase outsourcing services market size, by region, 2024 - 2032 (USD Million)
• TABLE 7 Global biomarker clinical phase outsourcing services market size, by biomarker type, 2018 - 2023 (USD Million)
• TABLE 8 Global biomarker clinical phase outsourcing services market size, by biomarker type, 2024 - 2032 (USD Million)
• TABLE 9 Global biomarker clinical phase outsourcing services market size, by therapeutic area, 2018 - 2023 (USD Million)
• TABLE 10 Global biomarker clinical phase outsourcing services market size, by therapeutic area, 2024 - 2032 (USD Million)
• TABLE 11 Global biomarker clinical phase outsourcing services market size, by end-user, 2018 - 2023 (USD Million)
• TABLE 12 Global biomarker clinical phase outsourcing services market size, by end-user, 2024 - 2032 (USD Million)
• TABLE 13 Industry impact forces
• TABLE 14 Surrogate endpoints market, 2018 - 2023 (USD Million)
• TABLE 15 Surrogate endpoints market, 2024 - 2032 (USD Million)
• TABLE 16 Predictive biomarker market, 2018 - 2023 (USD Million)
• TABLE 17 Predictive biomarker market, 2024 - 2032 (USD Million)
• TABLE 18 Prognostic biomarker market, 2018 - 2023 (USD Million)
• TABLE 19 Prognostic biomarker market, 2024 - 2032 (USD Million)
• TABLE 20 Safety biomarker market, 2018 - 2023 (USD Million)
• TABLE 21 Safety biomarker market, 2024 - 2032 (USD Million)
• TABLE 22 Other biomarker types market, 2018 - 2023 (USD Million)
• TABLE 23 Other biomarker types market, 2024 - 2032 (USD Million)
• TABLE 24 Oncology market, 2018 - 2023 (USD Million)
• TABLE 25 Oncology market, 2024 - 2032 (USD Million)
• TABLE 26 Neurology market, 2018 - 2023 (USD Million)
• TABLE 27 Neurology market, 2024 - 2032 (USD Million)
• TABLE 28 Cardiology market, 2018 - 2023 (USD Million)
• TABLE 29 Cardiology market, 2024 - 2032 (USD Million)
• TABLE 30 Autoimmune diseases market, 2018 - 2023 (USD Million)
• TABLE 31 Autoimmune diseases market, 2024 - 2032 (USD Million)
• TABLE 32 Other therapeutic areas market, 2018 - 2023 (USD Million)
• TABLE 33 Other therapeutic areas market, 2024 - 2032 (USD Million)
• TABLE 34 Pharmaceutical companies market, 2018 - 2023 (USD Million)
• TABLE 35 Pharmaceutical companies market, 2024 - 2032 (USD Million)
• TABLE 36 Biotechnology companies market, 2018 - 2023 (USD Million)
• TABLE 37 Biotechnology companies market, 2024 - 2032 (USD Million)
• TABLE 38 Other end-users market, 2018 - 2023 (USD Million)
• TABLE 39 Other end-users market, 2024 - 2032 (USD Million)
• TABLE 40 North America biomarker clinical phase outsourcing services market size, by country, 2018 - 2023 (USD Million)
• TABLE 41 North America biomarker clinical phase outsourcing services market size, by country, 2024 - 2032 (USD Million)
• TABLE 42 North America biomarker clinical phase outsourcing services market size, by biomarker type, 2018 - 2023 (USD Million)
• TABLE 43 North America biomarker clinical phase outsourcing services market size, by biomarker type, 2024 - 2032 (USD Million)
• TABLE 44 North America biomarker clinical phase outsourcing services market size, by therapeutic area, 2018 - 2023 (USD Million)
• TABLE 45 North America biomarker clinical phase outsourcing services market size, by therapeutic area, 2024 - 2032 (USD Million)
• TABLE 46 North America biomarker clinical phase outsourcing services market size, by end-user, 2018 - 2023 (USD Million)
• TABLE 47 North America biomarker clinical phase outsourcing services market size, by end-user, 2024 - 2032 (USD Million)
• TABLE 48 U.S. biomarker clinical phase outsourcing services market size, by biomarker type, 2018 - 2023 (USD Million)
• TABLE 49 U.S. biomarker clinical phase outsourcing services market size, by biomarker type, 2024 - 2032 (USD Million)
• TABLE 50 U.S. biomarker clinical phase outsourcing services market size, by therapeutic area, 2018 - 2023 (USD Million)
• TABLE 51 U.S. biomarker clinical phase outsourcing services market size, by therapeutic area, 2024 - 2032 (USD Million)
• TABLE 52 U.S. biomarker clinical phase outsourcing services market size, by end-user, 2018 - 2023 (USD Million)
• TABLE 53 U.S. biomarker clinical phase outsourcing services market size, by end-user, 2024 - 2032 (USD Million)
• TABLE 54 Canada biomarker clinical phase outsourcing services market size, by biomarker type, 2018 - 2023 (USD Million)
• TABLE 55 Canada biomarker clinical phase outsourcing services market size, by biomarker type, 2024 - 2032 (USD Million)
• TABLE 56 Canada biomarker clinical phase outsourcing services market size, by therapeutic area, 2018 - 2023 (USD Million)
• TABLE 57 Canada biomarker clinical phase outsourcing services market size, by therapeutic area, 2024 - 2032 (USD Million)
• TABLE 58 Canada biomarker clinical phase outsourcing services market size, by end-user, 2018 - 2023 (USD Million)
• TABLE 59 Canada biomarker clinical phase outsourcing services market size, by end-user, 2024 - 2032 (USD Million)
• TABLE 60 Europe biomarker clinical phase outsourcing services market size, by country, 2018 - 2023 (USD Million)
• TABLE 61 Europe biomarker clinical phase outsourcing services market size, by country, 2024 - 2032 (USD Million)
• TABLE 62 Europe biomarker clinical phase outsourcing services market size, by biomarker type, 2018 - 2023 (USD Million)
• TABLE 63 Europe biomarker clinical phase outsourcing services market size, by biomarker type, 2024 - 2032 (USD Million)
• TABLE 64 Europe biomarker clinical phase outsourcing services market size, by therapeutic area, 2018 - 2023 (USD Million)
• TABLE 65 Europe biomarker clinical phase outsourcing services market size, by therapeutic area, 2024 - 2032 (USD Million)
• TABLE 66 Europe biomarker clinical phase outsourcing services market size, by end-user, 2018 - 2023 (USD Million)
• TABLE 67 Europe biomarker clinical phase outsourcing services market size, by end-user, 2024 - 2032 (USD Million)
• TABLE 68 Germany biomarker clinical phase outsourcing services market size, by biomarker type, 2018 - 2023 (USD Million)
• TABLE 69 Germany biomarker clinical phase outsourcing services market size, by biomarker type, 2024 - 2032 (USD Million)
• TABLE 70 Germany biomarker clinical phase outsourcing services market size, by therapeutic area, 2018 - 2023 (USD Million)
• TABLE 71 Germany biomarker clinical phase outsourcing services market size, by therapeutic area, 2024 - 2032 (USD Million)
• TABLE 72 Germany biomarker clinical phase outsourcing services market size, by end-user, 2018 - 2023 (USD Million)
• TABLE 73 Germany biomarker clinical phase outsourcing services market size, by end-user, 2024 - 2032 (USD Million)
• TABLE 74 UK biomarker clinical phase outsourcing services market size, by biomarker type, 2018 - 2023 (USD Million)
• TABLE 75 UK biomarker clinical phase outsourcing services market size, by biomarker type, 2024 - 2032 (USD Million)
• TABLE 76 UK biomarker clinical phase outsourcing services market size, by therapeutic area, 2018 - 2023 (USD Million)
• TABLE 77 UK biomarker clinical phase outsourcing services market size, by therapeutic area, 2024 - 2032 (USD Million)
• TABLE 78 UK biomarker clinical phase outsourcing services market size, by end-user, 2018 - 2023 (USD Million)
• TABLE 79 UK biomarker clinical phase outsourcing services market size, by end-user, 2024 - 2032 (USD Million)
• TABLE 80 France biomarker clinical phase outsourcing services market size, by biomarker type, 2018 - 2023 (USD Million)
• TABLE 81 France biomarker clinical phase outsourcing services market size, by biomarker type, 2024 - 2032 (USD Million)
• TABLE 82 France biomarker clinical phase outsourcing services market size, by therapeutic area, 2018 - 2023 (USD Million)
• TABLE 83 France biomarker clinical phase outsourcing services market size, by therapeutic area, 2024 - 2032 (USD Million)
• TABLE 84 France biomarker clinical phase outsourcing services market size, by end-user, 2018 - 2023 (USD Million)
• TABLE 85 France biomarker clinical phase outsourcing services market size, by end-user, 2024 - 2032 (USD Million)
• TABLE 86 Spain biomarker clinical phase outsourcing services market size, by biomarker type, 2018 - 2023 (USD Million)
• TABLE 87 Spain biomarker clinical phase outsourcing services market size, by biomarker type, 2024 - 2032 (USD Million)
• TABLE 88 Spain biomarker clinical phase outsourcing services market size, by therapeutic area, 2018 - 2023 (USD Million)
• TABLE 89 Spain biomarker clinical phase outsourcing services market size, by therapeutic area, 2024 - 2032 (USD Million)
• TABLE 90 Spain biomarker clinical phase outsourcing services market size, by end-user, 2018 - 2023 (USD Million)
• TABLE 91 Spain biomarker clinical phase outsourcing services market size, by end-user, 2024 - 2032 (USD Million)
• TABLE 92 Italy biomarker clinical phase outsourcing services market size, by biomarker type, 2018 - 2023 (USD Million)
• TABLE 93 Italy biomarker clinical phase outsourcing services market size, by biomarker type, 2024 - 2032 (USD Million)
• TABLE 94 Italy biomarker clinical phase outsourcing services market size, by therapeutic area, 2018 - 2023 (USD Million)
• TABLE 95 Italy biomarker clinical phase outsourcing services market size, by therapeutic area, 2024 - 2032 (USD Million)
• TABLE 96 Italy biomarker clinical phase outsourcing services market size, by end-user, 2018 - 2023 (USD Million)
• TABLE 97 Italy biomarker clinical phase outsourcing services market size, by end-user, 2024 - 2032 (USD Million)
• TABLE 98 Rest of Europe biomarker clinical phase outsourcing services market size, by biomarker type, 2018 - 2023 (USD Million)
• TABLE 99 Rest of Europe biomarker clinical phase outsourcing services market size, by biomarker type, 2024 - 2032 (USD Million)
• TABLE 100 Rest of Europe biomarker clinical phase outsourcing services market size, by therapeutic area, 2018 - 2023 (USD Million)
• TABLE 101 Rest of Europe biomarker clinical phase outsourcing services market size, by therapeutic area, 2024 - 2032 (USD Million)
• TABLE 102 Rest of Europe biomarker clinical phase outsourcing services market size, by end-user, 2018 - 2023 (USD Million)
• TABLE 103 Rest of Europe biomarker clinical phase outsourcing services market size, by end-user, 2024 - 2032 (USD Million)
• TABLE 104 Asia Pacific biomarker clinical phase outsourcing services market size, by country, 2018 - 2023 (USD Million)
• TABLE 105 Asia Pacific biomarker clinical phase outsourcing services market size, by country, 2024 - 2032 (USD Million)
• TABLE 106 Asia Pacific biomarker clinical phase outsourcing services market size, by biomarker type, 2018 - 2023 (USD Million)
• TABLE 107 Asia Pacific biomarker clinical phase outsourcing services market size, by biomarker type, 2024 - 2032 (USD Million)
• TABLE 108 Asia Pacific biomarker clinical phase outsourcing services market size, by therapeutic area, 2018 - 2023 (USD Million)
• TABLE 109 Asia Pacific biomarker clinical phase outsourcing services market size, by therapeutic area, 2024 - 2032 (USD Million)
• TABLE 110 Asia Pacific biomarker clinical phase outsourcing services market size, by end-user, 2018 - 2023 (USD Million)
• TABLE 111 Asia Pacific biomarker clinical phase outsourcing services market size, by end-user, 2024 - 2032 (USD Million)
• TABLE 112 China biomarker clinical phase outsourcing services market size, by biomarker type, 2018 - 2023 (USD Million)
• TABLE 113 China biomarker clinical phase outsourcing services market size, by biomarker type, 2024 - 2032 (USD Million)
• TABLE 114 China biomarker clinical phase outsourcing services market size, by therapeutic area, 2018 - 2023 (USD Million)
• TABLE 115 China biomarker clinical phase outsourcing services market size, by therapeutic area, 2024 - 2032 (USD Million)
• TABLE 116 China biomarker clinical phase outsourcing services market size, by end-user, 2018 - 2023 (USD Million)
• TABLE 117 China biomarker clinical phase outsourcing services market size, by end-user, 2024 - 2032 (USD Million)
• TABLE 118 Japan biomarker clinical phase outsourcing services market size, by biomarker type, 2018 - 2023 (USD Million)
• TABLE 119 Japan biomarker clinical phase outsourcing services market size, by biomarker type, 2024 - 2032 (USD Million)
• TABLE 120 Japan biomarker clinical phase outsourcing services market size, by therapeutic area, 2018 - 2023 (USD Million)
• TABLE 121 Japan biomarker clinical phase outsourcing services market size, by therapeutic area, 2024 - 2032 (USD Million)
• TABLE 122 Japan biomarker clinical phase outsourcing services market size, by end-user, 2018 - 2023 (USD Million)
• TABLE 123 Japan biomarker clinical phase outsourcing services market size, by end-user, 2024 - 2032 (USD Million)
• TABLE 124 India biomarker clinical phase outsourcing services market size, by biomarker type, 2018 - 2023 (USD Million)
• TABLE 125 India biomarker clinical phase outsourcing services market size, by biomarker type, 2024 - 2032 (USD Million)
• TABLE 126 India biomarker clinical phase outsourcing services market size, by therapeutic area, 2018 - 2023 (USD Million)
• TABLE 127 India biomarker clinical phase outsourcing services market size, by therapeutic area, 2024 - 2032 (USD Million)
• TABLE 128 India biomarker clinical phase outsourcing services market size, by end-user, 2018 - 2023 (USD Million)
• TABLE 129 India biomarker clinical phase outsourcing services market size, by end-user, 2024 - 2032 (USD Million)
• TABLE 130 Australia biomarker clinical phase outsourcing services market size, by biomarker type, 2018 - 2023 (USD Million)
• TABLE 131 Australia biomarker clinical phase outsourcing services market size, by biomarker type, 2024 - 2032 (USD Million)
• TABLE 132 Australia biomarker clinical phase outsourcing services market size, by therapeutic area, 2018 - 2023 (USD Million)
• TABLE 133 Australia biomarker clinical phase outsourcing services market size, by therapeutic area, 2024 - 2032 (USD Million)
• TABLE 134 Australia biomarker clinical phase outsourcing services market size, by end-user, 2018 - 2023 (USD Million)
• TABLE 135 Australia biomarker clinical phase outsourcing services market size, by end-user, 2024 - 2032 (USD Million)
• TABLE 136 Rest of Asia Pacific biomarker clinical phase outsourcing services market size, by biomarker type, 2018 - 2023 (USD Million)
• TABLE 137 Rest of Asia Pacific biomarker clinical phase outsourcing services market size, by biomarker type, 2024 - 2032 (USD Million)
• TABLE 138 Rest of Asia Pacific biomarker clinical phase outsourcing services market size, by therapeutic area, 2018 - 2023 (USD Million)
• TABLE 139 Rest of Asia Pacific biomarker clinical phase outsourcing services market size, by therapeutic area, 2024 - 2032 (USD Million)
• TABLE 140 Rest of Asia Pacific biomarker clinical phase outsourcing services market size, by end-user, 2018 - 2023 (USD Million)
• TABLE 141 Rest of Asia Pacific biomarker clinical phase outsourcing services market size, by end-user, 2024 - 2032 (USD Million)
• TABLE 142 Latin America biomarker clinical phase outsourcing services market size, by country, 2018 - 2023 (USD Million)
• TABLE 143 Latin America biomarker clinical phase outsourcing services market size, by country, 2024 - 2032 (USD Million)
• TABLE 144 Latin America biomarker clinical phase outsourcing services market size, by biomarker type, 2018 - 2023 (USD Million)
• TABLE 145 Latin America biomarker clinical phase outsourcing services market size, by biomarker type, 2024 - 2032 (USD Million)
• TABLE 146 Latin America biomarker clinical phase outsourcing services market size, by therapeutic area, 2018 - 2023 (USD Million)
• TABLE 147 Latin America biomarker clinical phase outsourcing services market size, by therapeutic area, 2024 - 2032 (USD Million)
• TABLE 148 Latin America biomarker clinical phase outsourcing services market size, by end-user, 2018 - 2023 (USD Million)
• TABLE 149 Latin America biomarker clinical phase outsourcing services market size, by end-user, 2024 - 2032 (USD Million)
• TABLE 150 Brazil biomarker clinical phase outsourcing services market size, by biomarker type, 2018 - 2023 (USD Million)
• TABLE 151 Brazil biomarker clinical phase outsourcing services market size, by biomarker type, 2024 - 2032 (USD Million)
• TABLE 152 Brazil biomarker clinical phase outsourcing services market size, by therapeutic area, 2018 - 2023 (USD Million)
• TABLE 153 Brazil biomarker clinical phase outsourcing services market size, by therapeutic area, 2024 - 2032 (USD Million)
• TABLE 154 Brazil biomarker clinical phase outsourcing services market size, by end-user, 2018 - 2023 (USD Million)
• TABLE 155 Brazil biomarker clinical phase outsourcing services market size, by end-user, 2024 - 2032 (USD Million)
• TABLE 156 Mexico biomarker clinical phase outsourcing services market size, by biomarker type, 2018 - 2023 (USD Million)
• TABLE 157 Mexico biomarker clinical phase outsourcing services market size, by biomarker type, 2024 - 2032 (USD Million)
• TABLE 158 Mexico biomarker clinical phase outsourcing services market size, by therapeutic area, 2018 - 2023 (USD Million)
• TABLE 159 Mexico biomarker clinical phase outsourcing services market size, by therapeutic area, 2024 - 2032 (USD Million)
• TABLE 160 Mexico biomarker clinical phase outsourcing services market size, by end-user, 2018 - 2023 (USD Million)
• TABLE 161 Mexico biomarker clinical phase outsourcing services market size, by end-user, 2024 - 2032 (USD Million)
• TABLE 162 Rest of Latin America biomarker clinical phase outsourcing services market size, by biomarker type, 2018 - 2023 (USD Million)
• TABLE 163 Rest of Latin America biomarker clinical phase outsourcing services market size, by biomarker type, 2024 - 2032 (USD Million)
• TABLE 164 Rest of Latin America biomarker clinical phase outsourcing services market size, by therapeutic area, 2018 - 2023 (USD Million)
• TABLE 165 Rest of Latin America biomarker clinical phase outsourcing services market size, by therapeutic area, 2024 - 2032 (USD Million)
• TABLE 166 Rest of Latin America biomarker clinical phase outsourcing services market size, by end-user, 2018 - 2023 (USD Million)
• TABLE 167 Rest of Latin America biomarker clinical phase outsourcing services market size, by end-user, 2024 - 2032 (USD Million)
• TABLE 168 Middle East & Africa biomarker clinical phase outsourcing services market size, by country, 2018 - 2023 (USD Million)
• TABLE 169 Middle East & Africa biomarker clinical phase outsourcing services market size, by country, 2024 - 2032 (USD Million)
• TABLE 170 Middle East & Africa biomarker clinical phase outsourcing services market size, by biomarker type, 2018 - 2023 (USD Million)
• TABLE 171 Middle East & Africa biomarker clinical phase outsourcing services market size, by biomarker type, 2024 - 2032 (USD Million)
• TABLE 172 Middle East & Africa biomarker clinical phase outsourcing services market size, by therapeutic area, 2018 - 2023 (USD Million)
• TABLE 173 Middle East & Africa biomarker clinical phase outsourcing services market size, by therapeutic area, 2024 - 2032 (USD Million)
• TABLE 174 Middle East & Africa biomarker clinical phase outsourcing services market size, by end-user, 2018 - 2023 (USD Million)
• TABLE 175 Middle East & Africa biomarker clinical phase outsourcing services market size, by end-user, 2024 - 2032 (USD Million)
• TABLE 176 South Africa biomarker clinical phase outsourcing services market size, by biomarker type, 2018 - 2023 (USD Million)
• TABLE 177 South Africa biomarker clinical phase outsourcing services market size, by biomarker type, 2024 - 2032 (USD Million)
• TABLE 178 South Africa biomarker clinical phase outsourcing services market size, by therapeutic area, 2018 - 2023 (USD Million)
• TABLE 179 South Africa biomarker clinical phase outsourcing services market size, by therapeutic area, 2024 - 2032 (USD Million)
• TABLE 180 South Africa biomarker clinical phase outsourcing services market size, by end-user, 2018 - 2023 (USD Million)
• TABLE 181 South Africa biomarker clinical phase outsourcing services market size, by end-user, 2024 - 2032 (USD Million)
• TABLE 182 Saudi Arabia biomarker clinical phase outsourcing services market size, by biomarker type, 2018 - 2023 (USD Million)
• TABLE 183 Saudi Arabia biomarker clinical phase outsourcing services market size, by biomarker type, 2024 - 2032 (USD Million)
• TABLE 184 Saudi Arabia biomarker clinical phase outsourcing services market size, by therapeutic area, 2018 - 2023 (USD Million)
• TABLE 185 Saudi Arabia biomarker clinical phase outsourcing services market size, by therapeutic area, 2024 - 2032 (USD Million)
• TABLE 186 Saudi Arabia biomarker clinical phase outsourcing services market size, by end-user, 2018 - 2023 (USD Million)
• TABLE 187 Saudi Arabia biomarker clinical phase outsourcing services market size, by end-user, 2024 - 2032 (USD Million)
• TABLE 188 Rest of Middle East & Africa biomarker clinical phase outsourcing services market size, by biomarker type, 2018 - 2023 (USD Million)
• TABLE 189 Rest of Middle East & Africa biomarker clinical phase outsourcing services market size, by biomarker type, 2024 - 2032 (USD Million)
• TABLE 190 Rest of Middle East & Africa biomarker clinical phase outsourcing services market size, by therapeutic area, 2018 - 2023 (USD Million)
• TABLE 191 Rest of Middle East & Africa biomarker clinical phase outsourcing services market size, by therapeutic area, 2024 - 2032 (USD Million)
• TABLE 192 Rest of Middle East & Africa biomarker clinical phase outsourcing services market size, by end-user, 2018 - 2023 (USD Million)
• TABLE 193 Rest of Middle East & Africa biomarker clinical phase outsourcing services market size, by end-user, 2024 - 2032 (USD Million)

Charts & Figures

• FIG 1 GMI report coverage: critical research elements
• FIG 2 Top-down approach
• FIG 3 Market estimation and forecast methodology
• FIG 4 Market forecasting methodology
• FIG 5 Breakdown of primary participants
• FIG 6 Biomarker clinical phase outsourcing services market industry 360 degree synopsis, 2018 - 2032
• FIG 7 Industry landscape analysis, 2018 - 2032 (USD Million)
• FIG 8 Growth potential analysis, by biomarker type
• FIG 9 Growth potential analysis, by therapeutic area
• FIG 10 Growth potential analysis, by end-user
• FIG 11 Porter's analysis
• FIG 12 PESTEL analysis
• FIG 13 Company matrix analysis, 2022
• FIG 14 Competitive analysis of major market players, 2022
• FIG 15 Competitive positioning matrix, 2022
• FIG 16 Strategic dashboard, 2022